Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Bard to comarket ProstaScint with Cytogen

Aug. 16, 1996

White Iris leukocyte differential analyzer cleared for U.S. market

Aug. 9, 1996

OncorMed to offer genetic testing for BRC2 mutations

Aug. 9, 1996

BRACAone undergoes beta-site testing in U.S.

Aug. 9, 1996

Cyogen's ProstaScint on its way to FDA approval

July 26, 1996

Oncor obtains license to p43 blood test for early-stage breast cancer

July 26, 1996

ICD grants exclusive rights of DR-70 to Y.H. BioTek

July 26, 1996

Quidel's QuickVue Chlamydia Test approved in Germany

July 26, 1996

Contrast agents and antidotes described by Schering AG

July 26, 1996

Positive phase I/II trial results for Parkinson's diagnostic, Altropane

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...